Barclays’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1
Closed -$25 5364
2025
Q1
$25 Hold
1
﹤0.01% 5165
2024
Q4
$23 Hold
1
﹤0.01% 5215
2024
Q3
$21 Hold
1
﹤0.01% 5230
2024
Q2
$19 Hold
1
﹤0.01% 4781
2024
Q1
$19 Buy
+1
New +$20 ﹤0.01% 5023
2020
Q1
Sell
-11
Closed 6234
2019
Q4
$0 Buy
+11
New +$390 ﹤0.01% 6483
2019
Q1
Sell
-15,518
Closed -$503K 7104
2018
Q4
$503K Buy
15,518
+12,414
+400% +$501K ﹤0.01% 3817
2018
Q3
$159K Sell
3,104
-23,096
-88% -$1.16M ﹤0.01% 5179
2018
Q2
$1.32M Sell
26,200
-11,605
-31% -$588K ﹤0.01% 2974
2018
Q1
$1.93M Buy
37,805
+29,305
+345% +$1.56M ﹤0.01% 2496
2017
Q4
$447K Buy
8,500
+2,536
+43% +$126K ﹤0.01% 3967
2017
Q3
$291K Buy
5,964
+2,364
+66% +$112K ﹤0.01% 4110
2017
Q2
$174K Buy
+3,600
New +$166K ﹤0.01% 4484
2016
Q2
Sell
-138
Closed -$6K 6404
2016
Q1
$6K Buy
+138
New +$5.84K ﹤0.01% 5620
2015
Q4
Sell
-438
Closed -$17K 6158
2015
Q3
$17K Buy
438
+356
+434% +$14.5K ﹤0.01% 5540
2015
Q2
$3K Sell
82
-99
-55% -$4.23K ﹤0.01% 6675
2015
Q1
$7K Sell
181
-27,758
-99% -$1.07M ﹤0.01% 6417
2014
Q4
$1.03M Buy
27,939
+27,151
+3,446% +$978K ﹤0.01% 3183
2014
Q3
$27K Sell
788
-904
-53% -$31.2K ﹤0.01% 6296
2014
Q2
$56K Sell
1,692
-29
-2% -$967 ﹤0.01% 5848
2014
Q1
$59K Buy
1,721
+29
+2% +$1.02K ﹤0.01% 5863
2013
Q4
$59K Hold
1,692
﹤0.01% 6067
2013
Q3
$54K Sell
1,692
-460
-21% -$15K ﹤0.01% 6001
2013
Q2
$76K Buy
+2,152
New +$74.8K ﹤0.01% 6012

Other funds holding FMS

Barclays's FMS Position: Q2 2025 in Review

Barclays sold out of Fresenius Medical Care (FMS) in Q2 2025, closing a stake of 1 share — an estimated $25 sold.

Barclays first reported a position in FMS in Q2 2013 and held it in 24 quarters. The position peaked at $1.93M in Q1 2018. 207 funds tracked by Wall St. Rank hold FMS as of Q2 2025.

  • Barclays reported no remaining Fresenius Medical Care position as of Q2 2025 after selling out during the quarter.
  • Barclays sold 1 Fresenius Medical Care share in Q2 2025, an estimated $25.
  • Barclays first reported a position in Fresenius Medical Care in Q2 2013 and held it in 24 quarters.
  • Barclays's Fresenius Medical Care position peaked at $1.93M in Q1 2018.
  • 207 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2025.

Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.